Lonza
Sven Bieli is an accomplished Commercial Development Director at Lonza, with extensive experience in optimizing project portfolios and developing strategic plans for biotech business expansion since May 2014. Previous roles include Associate Director of Technical Sales & Proposals, where Sven generated tailored project solutions and supported startups and biopharma companies through pre-clinical development. Sven has held positions such as Team Leader, Proposal Management Biopharma, and Proposal Manager Biotech, demonstrating strong leadership and project management skills in the biopharmaceutical sector. Prior to Lonza, Sven gained experience as a Process Engineer at Janssen Inc. and a scientific Mitarbeiter at Index Nominum. Sven holds a Master of Science in Biochemistry and Molecular Biology from the University of Bern and an Executive MBA in Leadership and Management from Berner Fachhochschule BFH.
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.